What types of biologic/targeted therapies are available?
Thanks to endless hours of research and patients who have participated in clinical trials, we have several types of these therapies to use in our arsenal in the fight against cancer. They include:
Are there limitations to what these therapies can do?
Biologic/targeted therapies do have some limitations. Cancer cells can become resistant to the therapy. Either the target itself can change or mutate, so that the targeted therapy no longer interacts well with it. The other thing that can happen is that the tumor will find a new way to achieve tumor growth that does not depend on the target.
Is a biologic or targeted therapy ever used at the same time as chemotherapy?
Depending on cancer, sometimes a person may receive both treatments simultaneously.
Are there side effects from receiving a biologic/targeted cancer therapy?
Originally, it was expected that targeted cancer therapies would be less toxic than traditional chemotherapy drugs because cancer cells are more dependent on the targets than are normal cells. Like every patient though, the side effects vary depending on the patient’s health, type of cancer, and treatment that is used.
What is Biologic/Targeted Therapy?
Knowing how cancer cells develop helps physicians to understand how targeted therapy works. All of the tissue in your body is made up of cells. There are many different cell types and each type has a specific function. Cancer begins when specific genes in healthy cells change. The change is called a mutation.
Genes tell cells how to make proteins that keep the cell working. If the genes change, these proteins change, too. This makes cells divide abnormally or live too long. When this happens, the cells grow out of control and form a tumor.
Targeted cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecular targets that are involved in the growth, progression, and spread of cancer.
How is it different from chemotherapy?
Targeted therapies act on specific molecular targets that are associated with cancer. Most standard chemotherapies act on all rapidly dividing normal and cancerous cells. They are designed to interact with their target, whereas many standard chemotherapies are designed to kill cells.
Targeted therapies are often cytostatic, meaning that they block tumor cell growth. In comparison, standard chemotherapies are cytotoxic meaning that they kill tumor cells.
One approach to identify potential targets is to compare the amounts of individual proteins in cancer cells with those in normal cells. Proteins that are present in cancer cells, but not normal cells or that are more abundant in cancer cells, would be potential targets, especially if they are known to be involved in cell growth or survival.
An example is the human epidermal growth factor receptor 2 protein (HER-2) found in HER2 Positive Breast Cancer. HER-2 is expressed at high levels on the surface of some cancer cells. Targeted therapies are known as CD4K and CDK6 block proteins in hormone receptor-positive breast cancer cells, which helps stop the cells from dividing. This can slow cancer growth.
Another approach to identify potential targets is to determine whether cancer cells produce mutant/altered proteins that drive cancer progression. Abnormalities in chromosomes that are present in cancer cells, but not in normal cells, sometimes result in the creation of a fusion gene (a gene that incorporates parts of two different genes) whose product, is called a fusion protein. It is believed that this may drive cancer development. Genetic tests detect mutations or changes in the DNA of cancer cells.